|4Jan 28, 6:06 PM ET

CymaBay Therapeutics, Inc. 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 28, 2016

Insider Transaction Report

Form 4
Period: 2016-01-26
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2016-01-26+54,00054,000 total
    Exercise: $1.06Exp: 2026-01-25Common Stock (54,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -